MedTrace Logo

AIRFRAME: Artificial Intelligence for Recognition of Fetal bRain AnoMaliEs at Second Trimester Fetal Brain Scan

NCT06675266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-11-05

No results posted yet for this study

Summary

Obstetric ultrasound represents the standard of care for the screening of the fetal anomalies. However, its performance is dependent upon several parameters including type of anomaly, gestational age, maternal habitus and skills of the examiner. The use of Artificial Intelligence (AI) in medical diagnostics has been suggested not only to reduce the inter- and intra-operator variability, but also to compress the required time necessary to perform routine tasks, hence optimizing healthcare resources. Fetal brain abnormalities are among the most challenging fetal congenital anomalies in terms of ultrasound diagnosis, prenatal counseling and management. The access to new sources of technology, i.e. AI, has the potential to improve recognition, detection and localization of brain malformations. Therefore, we propose to develop an AI-based software, which would be capable to recognize the brain structures at antenatal ultrasound and discriminate between normal and abnormal fetal brain anatomy through fully automatic data processing.

Conditions

  • Fetal Anomalies
  • Brain Malformation

Interventions

DIAGNOSTIC_TEST

Development of AI algorithm for early detection of fetal brain anomalies in the second trimester screening scan

Development of AI algorithm for early detection of fetal brain anomalies in the second trimester of pregnancy

Sponsors & Collaborators

  • Ospedale Di Venere - Carbonara di Bari - Bari, Italy

    collaborator UNKNOWN

  • Azienda Ospedaliero-Universitaria di Parma

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Alessandra Familiari · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2024-12-30
Completion
2026-12-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06675266 on ClinicalTrials.gov